Search












The lists contain medicinal products or product categories subject to prescription which shall not bear the safety features (White list) and medicinal products or product categories not subject to prescription which shall bear the safety features (Black list)
Number of records: 6853
Name of the medicinal product Supplement
SÚKL code Registration Number SPC ? PIL ? ATC group MA status ?
RASILEZ HCT 300MG/12,5MG TBL FLM 50 I
0500475 EU/1/08/491/045 rasilezhct.pdf rasilezhct.pdf C09XA52 R
RASILEZ HCT 300MG/12,5MG TBL FLM 56 I
0500476 EU/1/08/491/046 rasilezhct.pdf rasilezhct.pdf C09XA52 R
RASILEZ HCT 300MG/12,5MG TBL FLM 90(3X30) I
0500477 EU/1/08/491/047 rasilezhct.pdf rasilezhct.pdf C09XA52 R
RASILEZ HCT 300MG/12,5MG TBL FLM 98(2X49) I
0500478 EU/1/08/491/048 rasilezhct.pdf rasilezhct.pdf C09XA52 R
RASILEZ HCT 300MG/12,5MG TBL FLM 280(20X14) I
0500479 EU/1/08/491/049 rasilezhct.pdf rasilezhct.pdf C09XA52 R
RASILEZ HCT 300MG/12,5MG TBL FLM 7 II
0500480 EU/1/08/491/050 rasilezhct.pdf rasilezhct.pdf C09XA52 R
RASILEZ HCT 300MG/12,5MG TBL FLM 14 II
0500481 EU/1/08/491/051 rasilezhct.pdf rasilezhct.pdf C09XA52 R
RASILEZ HCT 300MG/12,5MG TBL FLM 28 II
0500482 EU/1/08/491/052 rasilezhct.pdf rasilezhct.pdf C09XA52 R
RASILEZ HCT 300MG/12,5MG TBL FLM 30 II
0500483 EU/1/08/491/053 rasilezhct.pdf rasilezhct.pdf C09XA52 R
RASILEZ HCT 300MG/12,5MG TBL FLM 50 II
0500484 EU/1/08/491/054 rasilezhct.pdf rasilezhct.pdf C09XA52 R
RASILEZ HCT 300MG/12,5MG TBL FLM 56 II
0500485 EU/1/08/491/055 rasilezhct.pdf rasilezhct.pdf C09XA52 R
RASILEZ HCT 300MG/12,5MG TBL FLM 56X1 II
0500486 EU/1/08/491/056 rasilezhct.pdf rasilezhct.pdf C09XA52 R
RASILEZ HCT 300MG/12,5MG TBL FLM 90 II
0500487 EU/1/08/491/057 rasilezhct.pdf rasilezhct.pdf C09XA52 R
RASILEZ HCT 300MG/12,5MG TBL FLM 98 II
0500488 EU/1/08/491/058 rasilezhct.pdf rasilezhct.pdf C09XA52 R
RASILEZ HCT 300MG/12,5MG TBL FLM 98(2X49X1) II
0500489 EU/1/08/491/059 rasilezhct.pdf rasilezhct.pdf C09XA52 R
RASILEZ HCT 300MG/12,5MG TBL FLM 280(20X14) II
0500490 EU/1/08/491/060 rasilezhct.pdf rasilezhct.pdf C09XA52 R
RASILEZ HCT 300MG/25MG TBL FLM 7 I
0500491 EU/1/08/491/061 rasilezhct.pdf rasilezhct.pdf C09XA52 R
RASILEZ HCT 300MG/25MG TBL FLM 14 I
0500492 EU/1/08/491/062 rasilezhct.pdf rasilezhct.pdf C09XA52 R
RASILEZ HCT 300MG/25MG TBL FLM 28 I
0500493 EU/1/08/491/063 rasilezhct.pdf rasilezhct.pdf C09XA52 R
RASILEZ HCT 300MG/25MG TBL FLM 30 I
0500494 EU/1/08/491/064 rasilezhct.pdf rasilezhct.pdf C09XA52 R

‹‹ ‹ 100 170 180 190 200 210 217 218 219 220 221 222 223 224 225 226 227 230 240 250 260 270 300 › ››

Medicinal products reimbursed from health insurance are blue-tinged and marked with sign.

Medicinal products on the Czech market in line with periodical report from wholesalers in last 3 months (with monthly distance) are sign and are typed in bold

Last update of registration information: 24. September 2020 at 01:08
Last update of price and payment data: 1. September 2020 at 01:09